From post

Molecular docking studies of potent and selective orally bioavailable dihydro-pyrazole Gpr-40 agonists as Alpha-Glucosidase Inhibitors (AGIS)

, , , и . World Journal of Biology Pharmacy and Health Sciences, 13 (3): 094–100 (марта 2023)
DOI: 10.30574/wjbphs.2023.13.3.0117

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed.

 

Другие публикации лиц с тем же именем